ChemicalBook >
제품 카탈로그 >1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic Acid
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic Acid
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic Acid 속성
- 녹는점
- >271oC (dec.)
- 끓는 점
- 478.3±45.0 °C(Predicted)
- 밀도
- 1.745±0.06 g/cm3(Predicted)
- 저장 조건
- Sealed in dry,Room Temperature
- 용해도
- DMSO(약간 용해됨), 메탄올(약간 용해됨, 가열)
- 산도 계수 (pKa)
- 5.75±0.20(Predicted)
- 물리적 상태
- 고체
- 물리적 상태
- 단단한 모양
- 색상
- 흰색에서 옅은 베이지까지
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
| 그림문자(GHS): |
|
| 신호 어: |
Warning |
| 유해·위험 문구: |
| 암호 |
유해·위험 문구 |
위험 등급 |
범주 |
신호 어 |
그림 문자 |
P- 코드 |
| H302 |
삼키면 유해함 |
급성 독성 물질 - 경구 |
구분 4 |
경고 |
|
P264, P270, P301+P312, P330, P501 |
| H315 |
피부에 자극을 일으킴 |
피부부식성 또는 자극성물질 |
구분 2 |
경고 |
|
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
눈에 심한 자극을 일으킴 |
심한 눈 손상 또는 자극성 물질 |
구분 2A |
경고 |
|
P264, P280, P305+P351+P338,P337+P313P |
| H332 |
흡입하면 유해함 |
급성 독성 물질 흡입 |
구분 4 |
경고 |
|
P261, P271, P304+P340, P312 |
| H335 |
호흡 자극성을 일으킬 수 있음 |
특정 표적장기 독성 - 1회 노출;호흡기계 자극 |
구분 3 |
경고 |
|
|
|
| 예방조치문구: |
| P261 |
분진·흄·가스·미스트·증기·...·스프레이의 흡입을 피하시오. |
| P280 |
보호장갑/보호의/보안경/안면보호구를 착용하시오. |
| P305+P351+P338 |
눈에 묻으면 몇 분간 물로 조심해서 씻으시오. 가능하면 콘택트렌즈를 제거하시오. 계속 씻으시오. |
|
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic Acid C화학적 특성, 용도, 생산
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic Acid 준비 용품 및 원자재
원자재
준비 용품
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic Acid 공급 업체
글로벌( 87)공급 업체
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic Acid 관련 검색:
GATIFLOXACIN RELATED COMPOUND A
8-Fluoro-6-methoxy Moxifloxacin Dihydrochloride
Moxifloxacin Impurity 30
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid ethyl ester
3-Quinolinecarboxylic acid, 7-aMino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo-
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
Moxifloxacin Decarboxy Analog
1-Cyclopropyl-7-8-difluoro-6-Methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Ethyl Ester
Moxifloxacin Ethyl Ester
ethyl 1-cyclopropyl-8-ethoxy-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate
1-cyclopropyl-8-ethoxy-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-8-ethoxy-6-fluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)-
1-Cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxoq
Methyl 1-cyclopropyl-6-fluoro-7-(hexahydro-1H-pyrrolo [3, 4-b]pyridin-6(2H)-yl)-8-Methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate
N-Methyl Moxifloxacin
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
